JP2007502861A5 - - Google Patents

Download PDF

Info

Publication number
JP2007502861A5
JP2007502861A5 JP2006532538A JP2006532538A JP2007502861A5 JP 2007502861 A5 JP2007502861 A5 JP 2007502861A5 JP 2006532538 A JP2006532538 A JP 2006532538A JP 2006532538 A JP2006532538 A JP 2006532538A JP 2007502861 A5 JP2007502861 A5 JP 2007502861A5
Authority
JP
Japan
Prior art keywords
trna synthetase
composition
pharmaceutically acceptable
synthetase inhibitor
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006532538A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007502861A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/013614 external-priority patent/WO2005009336A2/en
Publication of JP2007502861A publication Critical patent/JP2007502861A/ja
Publication of JP2007502861A5 publication Critical patent/JP2007502861A5/ja
Pending legal-status Critical Current

Links

JP2006532538A 2003-05-01 2004-05-03 抗菌方法及び組成物 Pending JP2007502861A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US46737703P 2003-05-01 2003-05-01
US48648203P 2003-07-10 2003-07-10
PCT/US2004/013614 WO2005009336A2 (en) 2003-05-01 2004-05-03 Antibacterial methods and compositions

Publications (2)

Publication Number Publication Date
JP2007502861A JP2007502861A (ja) 2007-02-15
JP2007502861A5 true JP2007502861A5 (enExample) 2007-06-21

Family

ID=34107519

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006532538A Pending JP2007502861A (ja) 2003-05-01 2004-05-03 抗菌方法及び組成物

Country Status (6)

Country Link
US (1) US20040224981A1 (enExample)
EP (1) EP1619947A4 (enExample)
JP (1) JP2007502861A (enExample)
AU (1) AU2004258821A1 (enExample)
CA (1) CA2523651A1 (enExample)
WO (1) WO2005009336A2 (enExample)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004078119A2 (en) * 2003-03-03 2004-09-16 Replidyne Inc. Substituted thiophenes with antibacterial activity
WO2006102680A2 (en) 2005-03-23 2006-09-28 Oculus Innovative Sciences, Inc. Method of treating second and third degree burns using oxidative reductive potential water solution
WO2006117762A2 (en) 2005-05-03 2006-11-09 Ranbaxy Laboratories Limited Antimicrobial agents
BRPI0706677A2 (pt) 2006-01-20 2011-04-05 Oculus Innovative Sciences Inc métodos de tratamento ou prevenção de sinusite com solução aquosa com potencial de oxirredução
WO2008039639A2 (en) * 2006-09-26 2008-04-03 Crestone, Inc. Substituted thienopyridone compounds with antibacterial activity
CN101652140B (zh) * 2006-09-26 2013-07-10 克莱斯通公司 具有抗菌活性的对映体化合物
ES2552773T3 (es) 2009-02-27 2015-12-02 Atyr Pharma, Inc. Motivos estructurales de polipéptidos asociados con la actividad de señalización celular
WO2010148004A1 (en) 2009-06-15 2010-12-23 Oculus Innovative Sciences, Inc. Solution containing hypochlorous acid and methods of using same
CA2797093C (en) 2010-04-26 2019-10-29 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of cysteinyl-trna synthetase
CA2797362C (en) 2010-04-27 2020-12-08 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of isoleucyl trna synthetases
CA2797259C (en) 2010-04-27 2020-09-29 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of threonyl trna synthetases
WO2011139853A2 (en) 2010-04-28 2011-11-10 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of alanyl trna synthetases
US8986680B2 (en) 2010-04-29 2015-03-24 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Asparaginyl tRNA synthetases
EP2563383B1 (en) 2010-04-29 2017-03-01 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of valyl trna synthetases
WO2011139986A2 (en) 2010-05-03 2011-11-10 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of arginyl-trna synthetases
CA2797977C (en) 2010-05-03 2019-08-20 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-trna synthetases
AU2011248357B2 (en) 2010-05-03 2017-02-23 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of seryl-tRNA synthetases
CN103140233B (zh) 2010-05-03 2017-04-05 Atyr 医药公司 与甲硫氨酰‑tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的发现
EP2566499B1 (en) 2010-05-04 2017-01-25 aTyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of p38 multi-trna synthetase complex
US9062301B2 (en) 2010-05-04 2015-06-23 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutamyl-prolyl-tRNA synthetases
CA2799197C (en) 2010-05-14 2019-10-29 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-trna synthetases
US9034598B2 (en) 2010-05-17 2015-05-19 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of leucyl-tRNA synthetases
AU2011258106B2 (en) 2010-05-27 2017-02-23 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutaminyl-tRNA synthetases
CN103118694B (zh) 2010-06-01 2016-08-03 Atyr医药公司 与赖氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的发现
CA2804278C (en) 2010-07-12 2021-07-13 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of aspartyl-trna synthetases
EP2593126B1 (en) 2010-07-12 2017-09-20 aTyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of histidyl-trna synthetases
US8999321B2 (en) 2010-07-12 2015-04-07 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-tRNA synthetases
JP6116479B2 (ja) 2010-07-12 2017-04-19 エータイアー ファーマ， インコーポレイテッド グリシルｔＲＮＡ合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見
WO2012014109A1 (en) 2010-07-30 2012-02-02 Ranbaxy Laboratories Limited Heterocyclic sulfonamides as inhibitors of transfer rna synthetase for use as antibacterial agents
JP5964304B2 (ja) 2010-08-25 2016-08-03 エータイアー ファーマ， インコーポレイテッド チロシルｔＲＮＡ合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見
CA2812795C (en) 2010-10-06 2021-08-31 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related protein fragments of tryptophanyl trna synthetases
EP2624817A1 (en) * 2010-10-08 2013-08-14 Helperby Therapeutics Limited Novel composition
WO2012054738A1 (en) * 2010-10-22 2012-04-26 Brown University Combination of an aminoacyl - trna synthetase inhibitor with a further antibacterial agent for attenuating multiple drug resistance
WO2013022982A2 (en) 2011-08-09 2013-02-14 Atyr Pharma, Inc. Pegylated tyrosyl-trna synthetase polypeptides
US9816084B2 (en) 2011-12-06 2017-11-14 Atyr Pharma, Inc. Aspartyl-tRNA synthetases
WO2013086228A1 (en) 2011-12-06 2013-06-13 Atyr Pharma, Inc. Pegylated aspartyl-trna synthetase polypeptides
CN104220461A (zh) 2011-12-29 2014-12-17 Atyr医药公司 天冬氨酰-tRNA合成酶-FC缀合物
AU2013246418B2 (en) * 2012-04-13 2017-02-23 Becton, Dickinson And Company Reflex testing of samples using residual materials from a prior test
CN114717206A (zh) 2013-03-15 2022-07-08 Atyr 医药公司 组氨酰-trna合成酶-fc缀合物
US10913736B2 (en) 2014-08-22 2021-02-09 University Of Washington Specific inhibitors of methionyl-tRNA synthetase
JP2019196307A (ja) * 2016-09-15 2019-11-14 武田薬品工業株式会社 複素環アミド化合物
ES2994451T3 (en) 2017-04-20 2025-01-24 Atyr Pharma Inc Compositions for treating lung inflammation
WO2019140265A1 (en) * 2018-01-12 2019-07-18 President And Fellows Of Harvard College Trna synthetase inhibitors
TWI923608B (zh) * 2020-08-25 2026-05-01 大陸商杭州中美華東製藥有限公司 莫匹羅星的提取方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1196284A (en) * 1982-05-28 1985-11-05 Joshua Oduro-Yeboah Pharmaceutical formulations
GB8415579D0 (en) * 1984-06-19 1984-07-25 Beecham Group Plc Compounds
IE59628B1 (en) * 1986-06-26 1994-03-09 Beecham Group Plc Treatment of fungal infections
KR100374462B1 (ko) * 1993-10-22 2003-06-09 스미스클라인 비참 코포레이션 신규조성물
GB9424562D0 (en) * 1994-12-06 1995-01-25 Giltech Ltd Product
GB9507825D0 (en) * 1995-04-18 1995-05-31 Wet Pieter M De Method of treatment
US5726195A (en) * 1995-07-28 1998-03-10 Cubist Pharmaceuticals, Inc. Aminoacyl adenylate mimics as novel antimicrobial and antiparasitic agents
US6169102B1 (en) * 1996-06-25 2001-01-02 Takeda Chemical Industries, Ltd. Oxazolone derivatives and their use as anti-Helicobacter pylori agent
US6448059B1 (en) * 1996-09-13 2002-09-10 Thomas Jefferson University Methods and composition for inhibition of tRNA activities
US5824657A (en) * 1997-03-18 1998-10-20 Cubist Pharmaceuticals, Inc. Aminoacyl sulfamides for the treatment of hyperproliferative disorders
US5939458A (en) * 1997-09-22 1999-08-17 Henry; James P. Reduction of hair growth
CN1307565A (zh) * 1998-04-29 2001-08-08 史密丝克莱恩比彻姆有限公司 用作mrs抑制剂和杀菌剂的喹诺酮化合物
WO2000017206A1 (en) * 1998-09-18 2000-03-30 Cubist Pharmaceuticals, Inc. Tetracyclic heterocycles as antimicrobial agents
GB9822241D0 (en) * 1998-10-12 1998-12-09 Smithkline Beecham Plc Novel compounds
US6348482B1 (en) * 1999-05-05 2002-02-19 Merck & Co., Inc. Catechols as antimicrobial agents
EP1176959B1 (en) * 1999-05-05 2006-03-08 Merck & Co., Inc. Novel prolines as antimicrobial agents
GB9911594D0 (en) * 1999-05-19 1999-07-21 Smithkline Beecham Plc Novel compounds
WO2000071524A1 (en) * 1999-05-19 2000-11-30 Smithkline Beecham Plc 2-nh-pyridones and pyrimidones as mrs inhibitors
IL137363A (en) * 2000-07-18 2005-12-18 Agis Ind 1983 Ltd Pharmaceutical compositions containing mupirocin
GB0228545D0 (en) * 2002-12-06 2003-01-15 Glaxo Group Ltd Novel compounds
GB0302546D0 (en) * 2003-02-04 2003-03-12 Glaxo Group Ltd Novel compounds
WO2004078119A2 (en) * 2003-03-03 2004-09-16 Replidyne Inc. Substituted thiophenes with antibacterial activity
DE10318991A1 (de) * 2003-04-25 2004-11-18 Heraeus Kulzer Gmbh & Co. Kg Poröser Körper mit antibiotischer Beschichtung, Verfahren zur Herstellung sowie Verwendung

Similar Documents

Publication Publication Date Title
JP2021063088A5 (enExample)
CN1878757A (zh) 吡啶酮衍生物及其应用
AR055363A1 (es) Formulaciones farmaceuticas que comprenden un beta 2- agonista de accion prolongada para administracion por nebulizacion
EP1730163A4 (en) Pharmaceutical salts of 3-O- (3,3-dimethylsuccinyl) betulinic acid
EA201101671A1 (ru) Замещенные производные аминопропионовой кислоты в качестве ингибиторов неприлизина
HRP20120494T1 (hr) Derivati purina za uporabu kao agonista adenozin a2a receptora
JP2009545603A5 (enExample)
RU2009126767A (ru) Производное 1-фенил-1-тио-d-глюцитола
HRP20211762T1 (hr) Derivati benzoksaborola za liječenje bakterijskih infekcija
JP2009528372A5 (enExample)
JP2009544665A5 (enExample)
RU2011138962A (ru) Производные 4-изопропилфенилглюцита в качестве ингибиторов sglt1
EP1816122A3 (en) 3,4,5-substituted piperidines as therapeutic compounds
JP2005508368A5 (enExample)
RU2002100058A (ru) Кристаллические производные 1-метилкарбапенема
ATE388703T1 (de) Pharmazeutische formulierung des telmisartan natriumsalzes
SE0402762D0 (sv) Indazole sulphonamide derivatives
AR038618A1 (es) Forma poliformica cristalina de clorhidratos de irinotecan
EP1885380A4 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING ARSENE (III ACID), SODIUM SALT AND THEIR DERIVATIVES FOR THE TREATMENT OF UROGENITAL CANCER AND METASTASES THEREOF
JP2004532828A5 (enExample)
FR2906140B1 (fr) Forme galenique pour l'administration par voie trans-muqueuse de principes actifs
MA28862B1 (fr) Composition pharmaceutique sous forme de comprime a residence gastrique contenant un principe actif
JPWO2024181437A5 (enExample)
EP1855531A4 (en) METHOD FOR INCREASING THE ORAL BIOVERABILITY OF A MEDICAMENT AND COMPOSITIONS FROM LESS TOXIC OROTATE SALTS
RU2005128132A (ru) Лечение бактериальных заболеваний органов дыхания путем местного применения фторхинолонов